Charles Alpuche - Mar 9, 2023 Form 4 Insider Report for INSULET CORP (PODD)

Role: Advisor
Signature: /s/ Patricia K. Dolan, attorney-in-fact
Stock symbol: PODD
Transactions as of: Mar 9, 2023
Transactions value $: -$1,038,760
Form type: 4
Date filed: 3/10/2023, 03:27 PM
Previous filing: Mar 1, 2023
Next filing: Mar 14, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PODD	Common Stock	Options Exercise	$125K	+4K	+8.78%	$31.21^*	49.6K	Mar 9, 2023	Direct
transaction	PODD	Common Stock	Sale	-$1.16M	-4K	-8.07%	$290.90	45.6K	Mar 9, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PODD	Employee Stock Option (Right to Buy)	Options Exercise	$0	-4K	-10.06%	$0.00	35.7K	Mar 9, 2023	Common Stock	4K	$31.21	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $290.89 to $291.18. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F2	This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.

Content

The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $290.89 to $291.18. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.